Genzyme, Neozyme II Corp. deal

GENIZ and its cystic fibrosis R&D spinoff signed a definitive acquisition agreement under which GENZ will tender the 2.4 million NIIUF units outstanding for $45 per unit (see BioCentury Sept. 9). ...